Original Research
Published on 08 May 2025
Development of a lung immune prognostic index-based nomogram model for predicting overall survival and immune-related adverse events in non-small cell lung cancer patients treated with sintilimab
in Cancer Immunity and Immunotherapy
- 2,369 views